Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 2
2012 1
2013 1
2014 1
2015 5
2016 2
2017 2
2018 6
2019 11
2020 4
2021 6
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data.
Olkus A, Tomczak A, Berger AK, Rauber C, Puchas P, Wehling C, Longerich T, Mehrabi A, Chang DH, Liermann J, Schäfer S, Pfeiffenberger J, Jäger D, Michl P, Springfeld C, Dill MT. Olkus A, et al. Among authors: pfeiffenberger j. Target Oncol. 2024 Mar;19(2):213-221. doi: 10.1007/s11523-024-01044-1. Epub 2024 Feb 28. Target Oncol. 2024. PMID: 38416377 Free PMC article.
Correction to: The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation.
Lozanovski VJ, Khajeh E, Fonouni H, Pfeiffenberger J, von Haken R, Brenner T, Mieth M, Schirmacher P, Michalski CW, Weiss KH, Büchler MW, Mehrabi A. Lozanovski VJ, et al. Among authors: pfeiffenberger j. Langenbecks Arch Surg. 2022 Dec;407(8):3919. doi: 10.1007/s00423-022-02619-0. Langenbecks Arch Surg. 2022. PMID: 35867152 No abstract available.
Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma.
Mohr I, Vogeler M, Pfeiffenberger J, Sprengel SD, Klauss M, Radeleff B, Teufel A, Chang DH, Springfeld C, Longerich T, Merle U, Mehrabi A, Weiss KH, Mieth M. Mohr I, et al. Among authors: pfeiffenberger j. J Cancer Res Clin Oncol. 2022 Nov;148(11):3163-3174. doi: 10.1007/s00432-021-03900-3. Epub 2022 Jan 25. J Cancer Res Clin Oncol. 2022. PMID: 35076764 Free PMC article.
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study).
Engelmann C, Herber A, Franke A, Bruns T, Reuken P, Schiefke I, Zipprich A, Zeuzem S, Goeser T, Canbay A, Berg C, Trebicka J, Uschner FE, Chang J, Mueller T, Aehling N, Schmelzle M, Splith K, Lammert F, Lange CM, Sarrazin C, Trautwein C, Manns M, Häussinger D, Pfeiffenberger J, Galle PR, Schmiedeknecht A, Berg T. Engelmann C, et al. Among authors: pfeiffenberger j. J Hepatol. 2021 Dec;75(6):1346-1354. doi: 10.1016/j.jhep.2021.07.033. Epub 2021 Aug 5. J Hepatol. 2021. PMID: 34364917 Free article. Clinical Trial.
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities.
Wehling C, Dill MT, Olkus A, Springfeld C, Chang DH, Naumann P, Longerich T, Kratochwil C, Mehrabi A, Merle U, Pfeiffenberger J, Rupp C, Weiss KH, Mieth M. Wehling C, et al. Among authors: pfeiffenberger j. J Cancer Res Clin Oncol. 2021 Aug;147(8):2471-2481. doi: 10.1007/s00432-021-03528-3. Epub 2021 Feb 4. J Cancer Res Clin Oncol. 2021. PMID: 33537908 Free PMC article.
43 results